Sign in
4

Changes in Ownership

Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-21-018219

Chief Business Officer sold 7,500 shares at $18.10 ($135,750)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Martin Michael Robert Chief Business Officer 2021-09-07 Sale −7,500 $18.10 $135,750 176,861 D
Open-market sales · 7,500 sh · avg $18.10 · $135,750
Loading xslF345X03/wf-form4_163113146158608.xml…